Tech Diligence & Strategy
Independent technical diligence and strategy for investors and companies at the frontier of biotech.
Work with usReputation
"Dr. Kate Krueger and the team at Helikon are simply amazing... Kate and her exceptional multidisciplinary team help me cut through the noise to advance our shared vision for the future."Lowell Thompson — Serial Entrepreneur / Learn with Lowell
"Helikon takes a holistic approach to alternative meat innovation and provides crucial insights into the state of the science and the industry."Caroline Kolta — XPRIZE Program Lead
"[Helikon] has turned cellular agriculture from a fringe idea met with skepticism within the scientific community to a scientific pursuit."Isha Datar — New Harvest Executive Director
Most entities have a vested interest in the outcome of a strategy project or diligence process. Nonprofits promote a cause, and companies put their best foot forward. This makes sense but doesn't show the whole picture. At Helikon, our only job is to give you the whole picture.
As independent evaluators, we believe science comes first, so we don't take carry or equity for any diligence work. What unites us is a love of technology and a job well done.
01
Tech due diligence focused on core technologies, competitor analysis, and economic evaluation. Projects range from seven days to two months.
02
Targeted ESG reporting across precision fermentation, cell-based meat, alternative proteins, molecular farming, carbon capture, and more.
03
Deep analytical expertise to evaluate proof of concept technology for deep tech ventures requiring general technology evaluation.
04
Ongoing technical evaluation for managing a thriving innovation portfolio, including benchmarking and success metrics.
05
Seminars, workshops, fireside chats, and roundtables that bring bleeding-edge tech discussions to the right context.
06
Deep expertise from CRISPR to metabolic engineering to protein synthesis — and cutting-edge research in proteomics, transcriptomics, and computational modeling.
"[Helikon] is extremely knowledgeable in all things related to synthetic biology, and terrific at providing technical expertise and communicating hardcore scientific topics."— Nieves Martinez Marshall, Ph.D., Novel Farms Founder and CEO
We bring scientists from across disciplines to work together on some of the most challenging advisory and diligence work at the frontiers of biotech.
Our team brings deep scientific expertise across the entire range of synthetic biology. Our experience crosses from cutting-edge research in proteomics and transcriptomics, to advanced machine learning and computational modeling, to real-world applications like liposome encapsulation, protein production and expression, biophysical assays, and microfluidics.
We have evaluated over 41 companies in the past three years from seed to scale.
41+
Companies evaluated
3
Years of deep tech diligence
14
Expert team members
Managing Partner
Tissue Engineer, Yale
Microbiology, MIT
Chemist, Chicago
Microbiologist, Yale
Bioprocess Expert
Molecular Biologist, Columbia
Bioengineer, MIT
Graphic Designer
Chief of Staff
Biologist, UC San Diego
Biomedical Engineer, Cornell
Microbiologist, Yale
Biochemist, Yale
Apr 13, 2023
Mar 23, 2023
Mar 16, 2023
Nov 2, 2022
Join our monthly newsletter for the latest in frontier tech.
Our Team
Scientists from across disciplines working together on the most challenging tech advisory and due diligence work in frontier biotech.
Cell-Based Meat
Tissue Engineer, Yale University
Biochemist, Yale
Bioprocess Expert, Kendall Square
Biomedical Engineer, Kendall Square
Bioprocess
Bioprocess Expert, Kendall Square
Biomedical Engineer, Kendall Square
Bioengineer, MIT
Climate Biotechnology
Chemist, Chicago
Molecular Biologist, Columbia
Microbiologist, MIT
Biologist, UC San Diego
Fermentation & Molecular Farming
Microbiologist, Yale University
Microbiologist, Yale University
Microbiologist, MIT
Mission Control
Managing Partner
Design
Executive Administrator
Advisors
President and Founder of Good Food Institute
Co-Founder of IndieBio
Author of Clean Meat
Press
Helikon is frequently quoted by press outlets from CNN to Nature and the New Yorker. Read to learn more about frontier technologies and our perspectives on new developments.
The New Yorker
The Boston Globe
Popular Mechanics
Nature News In Focus
Insights
Our most recent thoughts on the state of the industry, frontier technologies, and the science behind them.
State of the Industry
Bio-based textiles made from bacteria, fungi, and plants rather than their typical animal source.
State of the Industry
A design methodology to create chemical compounds with minimal negative environmental impacts.
State of the Industry
Chicken eggs remain a popular food and an inexpensive source of several key nutrients.
State of the Industry
Biotechnology embraces precision fermentation and cell culture to better recapitulate animal-derived milk.
State of the Industry
New technologies enabling a diverse range of plant-based and precision-fermentation-produced cheeses.
Technical Analysis
Used to assess and predict the outcomes of any project that can be modeled quantitatively.
Regulatory
Any new food ingredient is subject to premarket FDA approval unless generally recognized as safe.
Synthetic Biology
The rapidly expanding engineered food market is gaining buzz with investors and future consumers.
Synthetic Biology
States move forward lifting restrictions as synthetic biology transforms cannabis production.
Regulatory · Cell-based Meat
Commentary on the CFA's latest panel on cultured meat policy.
Synthetic Biology
Beer is America's favorite alcohol — and synthetic biology is transforming how it's made.
Alternative Food & Protein
New evidence on how our gut microbiome is shaped by diet and its impact on heart health.
Published
Helikon shares thoughts with leaders in the biotech, frontier tech, and tough tech space.
Watch and learn more about our science and perspectives on the future of food and biotech.
Contact
Reach out to discuss operational and technical diligence. We'd love to hear about what you're working on.
Phone
(203) 909-2023